-Ramsaran, New GPC
Health Minister Dr. Bheri Ramsaran has appealed to Guyanese to await the outcome of a bid-evaluation before jumping to conclusions about the huge difference in bids for anti-malarial drugs by two prospective suppliers.
“I would like to point out that at this very early stage, the bids have just been opened and the evaluation of these bids has to be done according to established procedure of the evaluation committee,” Ramsaran was quoted as saying on Friday by the Government Information Agency (GINA), even as supplier New GPC said that its bid was based on the supply of a branded drug that costs more than generic drugs. “I would like also to point out that the discrepancy between the amounts of monies that are indicated in the article may well be explained when this evaluation process would have been completed. The Ministry of Health awaits that report and by extension the Government of Guyana awaits that report.”
When bids for the supply and delivery of anti-malaria drugs for the Ministry of Health were opened last Tuesday, there was a difference of over $228M between the only
